Live Breaking News & Updates on Infresenius Kabi

1. COVID-19: CIPO, Federal Courts, Health Canada
In response to the pandemic, we saw quick action and flexibility from:
the
Canadian Intellectual Property Office (CIPO) – deadlines from March 16 to August 28 were extended until August 31. On December 14, the Trademarks Office began accepting requests for expedited examination of trademark applications associated with medical goods or services related to COVID-19;
the
Federal Courts – Federal Court (FC) deadlines were suspended until June 29 or July 13, depending on the province, and a number of hearings and patent trials were conducted by Zoom. Federal Court of Appeal (FCA) deadlines continue to be suspended for some appeals, but are being lifted for selected files on a weekly basis. The FC held that the 45-day time limit for commencing a s. 6(1) action under the ....

Astrazenecav Sandoz , Urszula Wojtyra , Eli Lillyv Teva , Infresenius Kabi , Katie Lee , Fresenius Kabi , Eli Lillyv Mylan , Janssenv Teva , Hospirav Kennedy , Pharmasciencev Bayer , Eli Lillyv Apotex , Allerganv Sandoz , Eli Lillyv Pharmascience , Apotexv Allergan , Eli Lilly , Trademarks Office , Quebec Superior Court On , House Of Commons Standing Committee On Health , Canadian Intellectual Property Office , Health Canada , Federal Courts , Amended Regulations , Federal Court , Patented Medicines , Time Limits , Interim Order ,